無料プレビュー

Heartflow, Inc. Common Stock (HTFL) · NASDAQ Global Select

プロフィール

Heartflow develops AI-powered software that analyzes coronary computed tomography angiography (CCTA) images to diagnose and manage coronary artery disease (CAD) with greater accuracy than traditional non-invasive tests. The company offers three main products: Heartflow FFRCT Analysis (blood flow assessment), Heartflow RoadMap Analysis (workflow optimization), and Heartflow Plaque Analysis (plaque characterization), with a fourth product expected in 2026. Heartflow operates through a direct sales model in the United States and select international markets, generating revenue on a pay-per-click

主要指標

株価: $47.63 (-3.50%)
時価総額: 41億ドル
PER（今期予想）: -114.8
PBR: 14.7
配当利回り: —
52週レンジ: $20.13 – $54.32
業種: Healthcare / Medical - Healthcare Information Services
上場: NASDAQ Global Select
構成銘柄: —

比較会社: BTSG BrightSpring Health Services, Inc. Common Stock、TEM Tempus AI, Inc.、SGFY Signify Health, Inc.、HQY HealthEquity, Inc.、HNGE Hinge Health, Inc.、RCM R1 RCM Inc.、DOCS Doximity, Inc.、WAY Waystar Holding Corp.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-11 · 更新: 2026-10-09